Theophylline toxicity: Difference between revisions

(Text replacement - "==References== " to "==References== <references/> ")
Line 45: Line 45:
#*[[IV Fluids]] for [[hypotension]]
#*[[IV Fluids]] for [[hypotension]]
#*Beta blockers for [[tachyarrhymias]]
#*Beta blockers for [[tachyarrhymias]]
#**[[Esmolol]] particularly wise first-line agent
#**Controversial, involve a toxicologist
#**Controversial, involve a toxicologist
#GI decontamination ([[Multidose Activated Charcoal]], [[Whole Bowel Irrigation]])
#GI decontamination ([[Multidose Activated Charcoal]], [[Whole Bowel Irrigation]])

Revision as of 04:22, 9 November 2018

See theophylline for general drug information.

Background

  • Still used in patients with debilitating brochospastic disease
  • Studied for treatment of Acute Mountain Sickness and Contrast-Induced Nephropathy
  • PO in elixir, extended release, or controlled release forms but absorption erratic
  • IV as aminophylline
  • Adenosine antagonism, Increase catecholamines, and Phosphodiesterase inhibition

Clinical Features

Differential Diagnosis

Evaluation

  • ECG
  • Chem
  • CK
  • Theophylline level

Management

  1. Supportive care
    • Cardiac monitoring
    • Ondansetron (Zofran) for antiemetic
    • EEG for sedated and paralyzed patients
  2. Cardiovascular
  3. GI decontamination (Multidose Activated Charcoal, Whole Bowel Irrigation)
  4. Seizures
    • Lorazepam (Ativan) 1st line
    • Phenobarbital if lorazepam ineffective
    • Phenytoin (Dilantin) contraindicated as increases seizure in animal studies
  5. Dialysis
    • Indicated in seizures, severe arrhythmias
    • Theophylline level >90mcg/ml in acute ingestion
    • Theophylline level >40mcg/ml in chronic ingestion

Disposition

Immediate release

  • Home after 6 hours if:
    • nontoxic
    • asymptomatic
    • and, normal vital sign

Sustained release

  • Home after 12 hours if:
    • nontoxic
    • asymptomatic
    • and, normal vital sign

See Also

External Links

References